Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sergio Carminati
Observed names:
S. CARMINATI,
S. Carminati
Institutions:
University of Milan,
Mario Negri Institute for Pharmacological Research
Observed institutions:
University of Milan,
Mario Negri Institute for Pharmacological Research
ORCID:
0000-0002-4330-6339
Observed ORCID:
0000-0002-4330-6339
OpenAlex ID:
A5017234835
Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study
2016
·
Bogdan Ene-Iordache
, Norberto Perico
, et al.
·
The Lancet Global Health
·
730
PDF
Sirolimus Therapy to Halt the Progression of ADPKD
2010
·
Norberto Perico
, Luca Antiga
, et al.
·
Journal of the American Society of Nephrology
·
188
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial
2012
·
Ida Martinelli
, Piero Ruggenenti
, et al.
·
Blood
·
139
PDF
Burden of CKD, Proteinuria, and Cardiovascular Risk Among Chinese, Mongolian, and Nepalese Participants in the International Society of Nephrology Screening Programs
2010
·
Sanjib Kumar Sharma
, Hequn Zou
, et al.
·
American Journal of Kidney Diseases
·
81
Long-term Effects of Octreotide on Liver Volume in Patients With Polycystic Kidney and Liver Disease
2016
·
Antonio Pisani
, Massimo Sabbatini
, et al.
·
Clinical Gastroenterology and Hepatology
·
76
Effects of Add-on Fluvastatin Therapy in Patients with Chronic Proteinuric Nephropathy on Dual Renin-Angiotensin System Blockade: The ESPLANADE Trial
2010
·
Piero Ruggenenti
, Annalisa Perna
, et al.
·
Clinical Journal of the American Society of Nephrology
·
48
Preventing renal and cardiovascular risk by renal function assessment: insights from a cross-sectional study in low-income countries and the USA
2012
·
Paolo Cravedi
, Sanjib Kumar Sharma
, et al.
·
BMJ Open
·
39
PDF
Developing Regulatory-compliant Electronic Case Report Forms for Clinical Trials: Experience with The Demand Trial
2009
·
B. Ene-Iordache
, S. Carminati
, et al.
·
Journal of the American Medical Informatics Association
·
37
PDF
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial
2017
·
Aneliya Parvanova
, Matias Trillini
, et al.
·
The Lancet Diabetes & Endocrinology
·
33
PDF
Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial
2019
·
Barbara Ruggiero
, Matias Trillini
, et al.
·
American Journal of Kidney Diseases
·
28
Prevalence of Hypertension and Diabetes and Coexistence of Chronic Kidney Disease and Cardiovascular Risk in the Population of the Republic of Moldova
2012
·
Igor Codreanu
, Vera Sali
, et al.
·
International Journal of Hypertension
·
22
PDF
Management of chronic kidney disease and its risk factors in eastern Nepal
2014
·
Sanjib Kumar Sharma
, Anup Ghimire
, et al.
·
The Lancet Global Health
·
19
PDF
Do attributes of persons with chronic kidney disease differ in low-income and middle-income countries compared with high-income countries? Evidence from population-based data in six countries
2017
·
Shuchi Anand
, Yuanchao Zheng
, et al.
·
BMJ Global Health
·
17
PDF
Hypertension and kidney function in an adult population of W est B engal, I ndia: Role of body weight, waist circumference, proteinuria and rural area living
2013
·
Maurizio Gallieni
, Bogdan Ene‐Iordache
, et al.
·
Nephrology
·
12
Salty tea intake and hypertension in Mongolia
2009
·
T. ARIUNAA
, N. PERICO
, et al.
·
International Journal of Cardiology
·
1
SAT-148 Determinants of outcomes in pediatric chronic kidney disease [CKD] in a low resource setting
2020
·
A. Iyengar
, P. Pais
, et al.
·
Kidney International Reports
Show more works
View as search
Works count:
16
Citation count:
1,469
H-index:
13
I10-index:
14
Year
Topic
Type